头颈部鳞状细胞癌初诊评估中发现非特异性肺结节的临床意义
回顾性分析本院诊治的头颈部鳞状细胞癌患者,初始评估发现的非特异性肺结节经系列胸部CT监测,比较有无结节患者的肺部恶性肿瘤累积发生率及生存率。非特异性肺结节不预测肺部恶性肿瘤风险,颈部淋巴结受累和血小板淋巴细胞比值≥126可能是影响无肺部恶性肿瘤生存的独立预后因素。
要点
- 初诊发现非特异性肺结节不提示后续肺部恶性肿瘤风险升高。
- 有无非特异性肺结节患者的总生存和无肺部恶性肿瘤生存无显著差异。
- 颈部淋巴结受累和血小板淋巴细胞比值≥126可能是影响无肺部恶性肿瘤生存的独立预后因素。
核心结论
- 头颈部鳞状细胞癌初诊评估中发现的非特异性肺结节不预测肺部恶性肿瘤风险;颈部淋巴结受累和血小板淋巴细胞比值≥126可能是影响无肺部恶性肿瘤生存的独立预后因素,与结节状态无关。
研究设计与样本
- 回顾性分析本院诊断和治疗的头颈部鳞状细胞癌患者病历,初始评估后经系列胸部CT监测非特异性肺结节变化,共158例(49.4%)无结节和162例(50.6%)有结节。
诊断标准与关键数值
- 治疗后2年肺部恶性肿瘤累积发生率在无结节患者为9.0%、有结节患者为6.2%。
临床应用与阅片要点
- 初诊发现非特异性肺结节时,可结合颈部淋巴结状态和血小板淋巴细胞比值≥126评估无肺部恶性肿瘤生存风险。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: We aimed to identify the clinical implications of nonspecific pulmonary nodules (NPNs) detected in the initial staging workup for patients with head and neck squamous cell carcinoma (HNSCC).
METHODS: Medical records of patients who had been diagnosed and treated in our hospital were retrospectively analysed. After definite treatment, changes of NPNs detected on initial evaluation were monitored via serial chest computed tomography. The associations between NPNs and the clinicopathological characteristics of primary HNSCC were evaluated. Survival analyses were performed according to the presence of NPNs.
RESULTS: The study consisted of 158 (49.4%) patients without NPNs and 162 (50.6%) patients with NPNs. The cumulative incidence of probabilities of pulmonary malignancy (PM) development at 2 years after treatment were 9.0% and 6.2% in NPN-negative and NPN-positive patients, respectively. Overall and PM-free survival rates were not significantly different according to NPN status. Cervical lymph node (LN) involvement and a platelet-lymphocyte ratio (PLR) ≥126 increased the risk of PMs (both P <0.05).
CONCLUSIONS: NPNs detected in the initial evaluation of patients with HNSCC did not predict the risk of pulmonary malignancies. Cervical LN involvement and PLR ≥126 may be independent prognostic factors affecting PM-free survival regardless of NPN status.
KEY POINTS: • We aimed to identify the clinical implications of nonspecific pulmonary nodules (NPNs). • NPNs in head and neck cancer patients do not lead to pulmonary malignancies (PMs). • NPNs are not associated with overall or PM-free survival (PMFS). • Cervical lymph node involvement is an independent prognostic factor affecting PMFS. • Platelet-lymphocyte ratio ≥126 is another predictor of PMFS regardless of NPN presence.
引用
- Kwon M, Lee SH, Lee YS, et al. Clinical implications of nonspecific pulmonary nodules identified during the initial evaluation of patients with head and neck squamous cell carcinoma. Eur Radiol. 2017. PMID: 28168367. doi:10.1007/s00330-017-4750-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。